TNF and Cirrhosis: Patients with dysmetabolic cirrhosis and obesity display a condition of chronic inflammation with production of cytokines (at first IFN-gamma and then TNF-alpha), which cause alterations in intestinal tight junctions and in gut microbiota, thus compromising the function and integrity of the intestinal barrier.